透過您的圖書館登入
IP:18.117.81.240
  • 期刊
  • OpenAccess

Uterine Papillary Serous Carcinoma Involving the Benign Cystic Teratoma of Ovary: An Unusual Case Report and Review of Literature

子宮乳突狀漿液性癌合併卵巢畸胎瘤:一罕見病例報告與文獻回顧

摘要


子宮之乳突狀漿液性癌(uterine papillary serous carcinorna; UPSC)是一種相當罕見的子宮內膜癌。與典型的子宮內膜癌不同的是,它具有高度侵犯性、高復發率與預後極差等特性。因此其最佳之治療方式目前仍未定論。卵巢之畸胎瘤(teratorna) 多發生於生育期之婦女,卵巢之畸胎瘤若發生於停經後之婦女則相當罕見。若患者同時合併有子宮乳突狀漿被性癌與卵巢畸胎瘤則更罕見,但目前文獻尚未有此類病例報告。因此特別藉報告一位74歲停經後婦女合併子宮乳突狀漿液性癌與卵巢畸胎瘤之病例,回顧文獻,來探討子宮乳突狀漿液性癌與卵巢畸胎瘤,並找出子宮乳突狀漿液性癌的最佳治療方式。我們的結論是了解子宮乳突狀漿液性癌具有高度侵犯性、高復發率與預後極差等特性是非常重要的。子宮乳突狀漿液性癌的治療與預後主要決定於仔細且完整的手術分期。其手術方法必須與卵巢癌的手術方法相同。疾病早期患者,術後可考慮輔助以放射治療;疾病晚期患者,術後則必須輔助以化學治療。合併使用paclitaxel與carboplatin,是目前最好的化學治療方式。

並列摘要


Uterine papillary serous carcinoma (UPSC) is an uncommon and peculiar variant of endometrial cancer characterized by aggressive nature, high relapse rate, and poor prognosis. We report a 74-year-old female with UPSC involving the benign cystic teratoma of ovary. To our knowledge, this is the first report of UPSC combined with ovarian benign cystic teratoma. We emphasize a careful staging laparotomy similar to the procedure undertaken for patients with ovarian carcinoma, postoperative adjuvant pelvic radiotherapy for early-stage disease, and adjuvant systemic chemotherapy for advanced-stage disease.

延伸閱讀